Vivos Therapeutics Inc (VVOS) - News Archive

Innovative Trends in Pediatric Obstructive Sleep Apnea: Vivos Therapeutics Landmark Clinical Trial Results Pediatric obstructive sleep apnea (OSA) presents significant challenges, both to clinical management and overall...

Vivos Therapeutics Moves to Expand Reach with Acquisition of Largest Sleep Center Operator in Nevada Las Vegas, NV Vivos Therapeutics Inc. (NASDAQ: VVOS) has announced a definitive agreement to acquire the largest sleep...

In a pivotal advancement for the treatment of obstructive sleep apnea (OSA), Vivos Therapeutics has been granted new Current Procedural Terminology (CPT) coverage and reimbursement codes by the American Medical Associat...

Analyzing Vivos Therapeutics Strategic Move: A New Offering and Its Implications for ShareholdersVivos Therapeutics, Inc. (NASDAQ: VVOS), based in Littleton, Colorado, has recently announced a definitive agreement with...

In a landmark moment for pediatric healthcare, Vivos Therapeutics has announced that it has received FDA 510(k) clearance to market its innovative sleep apnea treatment solutions aimed at addressing moderate to severe o...

Vivos Therapeutics: Revolutionizing Sleep Treatment with Strategic Alliance and Private Equity InvestmentIn a critical pivot towards enhancing revenue streams and potential profit, Vivos Therapeutics recently announced...

Breaking developments in the field of sleep disorder treatments have been announced, as Vivos Therapeutics’ flagship CARE Oral devices receive full approval for Medicare reimbursement. This marks a significant achieveme...

Healthcare innovation firm, Vivos Therapeutics, is experiencing a fortuitous upward trajectory in the market, spurred by recent developments with significant implications for the future of oral appliance therapies and s...

In a groundbreaking development, Vivos Therapeutics has achieved a significant milestone with the issuance of a FDA 510(k) clearance for its CARE oral medical devices designed to treat severe Obstructive Sleep Apnea (OS...

Vivos Therapeutics, a leading medical technology company specializing in innovative treatments for patients with dentofacial abnormalities and mild-to-moderate obstructive sleep apnea (OSA) and snoring in adults, recent...

Vivos Therapeutics Raises Funds for Innovative Dentofacial Abnormalities and Sleep Apnea Treatments through Private PlacementLittleton, Colo. - Vivos Therapeutics, a leading medical technology company dedicated to devel...

Vivos Therapeutics, a leading healthcare company focused on treating sleep-related breathing disorders, has recently announced a significant move to enhance its financial position. The company will proceed with a 1-for-...

Vivos Therapeutics, a leading provider of oral appliances for treating sleep apnea, has recently signed an exclusive nationwide distribution agreement with Lincare. This strategic partnership aims to expand the reach of...